Q1WB
IBB icon

Quest 10 Wealth Builders’s iShares Biotechnology ETF IBB Stock Holding History

Quest 10 Wealth Builders’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.57K Sell
24
-1
-4% -$172 ﹤0.01% 546
2026
Q1 		$4.22K Hold
25
– – ﹤0.01% 549
2025
Q4 		$4.22K Hold
25
– – ﹤0.01% 516
2025
Q3 		$3.61K Sell
25
-1
-4% -$136 ﹤0.01% 539
2025
Q2 		$3.29K Hold
26
– – ﹤0.01% 542
2025
Q1 		$3.33K Hold
26
– – ﹤0.01% 518
2024
Q4 		$3.44K Buy
+26
New +$3.65K ﹤0.01% 547

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Quest 10 Wealth Builders's IBB Position: Q2 2026 in Review

Quest 10 Wealth Builders reduced its iShares Biotechnology ETF (IBB) stake by 4% in Q2 2026, selling an estimated $172 and leaving 24 shares worth $4.57K. The position accounts for ﹤0.01% of the portfolio, ranked #546.

Quest 10 Wealth Builders first reported a position in IBB in Q4 2024 and has held it in 7 quarters since. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Quest 10 Wealth Builders held 24 shares of iShares Biotechnology ETF worth $4.57K as of Q2 2026.
  • Quest 10 Wealth Builders sold 1 iShares Biotechnology ETF share in Q2 2026, an estimated $172.
  • iShares Biotechnology ETF made up ﹤0.01% of Quest 10 Wealth Builders's portfolio in Q2 2026, its #546 holding.
  • Quest 10 Wealth Builders first reported a position in iShares Biotechnology ETF in Q4 2024 and has held it in 7 quarters since.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Quest 10 Wealth Builders's 13F filing for Q2 2026, filed 24 Jul 2026.